Navigation Links
Medivation Reports Year-End 2007 Financial Results and Pipeline Progress
Date:2/19/2008

t on Form 10-KSB for the year ended December 31, 2007, include information about additional factors that could affect the Company's financial and operating results.

- financial statements to follow -

MEDIVATION, INC.

(A DEVELOPMENT STAGE COMPANY)

CONSOLIDATED BALANCE SHEET

December 31, 2007

ASSETS

Current assets:

Cash and cash equivalents $43,258,479

Prepaid expenses and other current assets 990,909

Total current assets 44,249,388

Property and equipment (net of accumulated depreciation and

amortization of $69,474) 688,743

Intellectual property (net of accumulated amortization

of $16,673) 58,327

Other non-current assets 599,601

Total assets $45,596,059

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable $3,884,995

Other current liabilities 149,777

Total current liabilities 4,034,772

Other non-current liabilities 492,109

Series A redeemable preferred stock 11,000

Total liabilities 4,537,881

Commitments and contingencies

Stockholders' equity:

Preferred stock, $0.01 par value per share;

1,000,000 shares authorized; no shares issued and outstanding -

Common stock, $0.01 par value per share;

50,
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Medivation Announces Participation in Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
2. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
3. United Therapeutics Reports Fourth Quarter and Annual 2007 Financial Results
4. Favrille Reports Fourth Quarter and Year End 2007 Financial Results
5. JADO Reports Clinical Proof of Concept With Raft Modulator in Atopic Dermatitis
6. OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports
7. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
8. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
9. Escalon(R) Reports Second Quarter Fiscal 2008 Results
10. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
11. Eklin Medical Reports Record Revenues for 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... new study by researchers from the University of ... nanosystems function, unlocking the potential to create new ... which has been published in the prestigious academic ... novel laser technique to examine in rich detail ... small cluster containing an acetylene molecule and a ...
(Date:7/25/2014)... Livermore, California (PRWEB) July 25, 2014 ... been named to Thomson Reuters list of " The ... Pitz are part of the 3,000 researchers who were ... years to recognize those who published the highest-impact work ... numerous research papers on combustion modeling . , ...
(Date:7/24/2014)... York, NY - July 24, 2014 -- Keryx Biopharmaceuticals, ... from the long-term, randomized, active control Phase 3 study ... iron-based phosphate binder, for the treatment of hyperphosphatemia in ... PERFECTED study (PhosphatE binding and iRon delivery with FErric ... Journal of the American Society of Nephrology ...
(Date:7/24/2014)...  ECC West Africa, LLC (ECC) signed a contract ... College Hospital (UCH) Ibadan Board of Management for the ... construct, and operate and maintain a new, state-of-the-art Cancer ... the first of the 4-phase project, ECC will conduct ... UCH Ibadan intends to finance and develop the Cancer ...
Breaking Biology Technology:Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3Scientists Burst onto Influential List for Combustion Research 2Scientists Burst onto Influential List for Combustion Research 3Scientists Burst onto Influential List for Combustion Research 4Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2
... Researchers at Rensselaer Polytechnic Institute have developed ... a key step for advancing integrated 3-D chip ... or anneal, at about 300 degrees Celsius. This ... ideal for use in heat-sensitive nanoelectronics, particularly for ...
... H. Robert Superko, MD, principal investigator in the landmark ... at Saint Joseph,s Hospital in Atlanta, released preliminary findings ... risk of suffering sudden death or other significant cardiac ... hundred percent increased risk for cardiac disease as compared ...
... Cardio-diagnostic company adds new apoAI measurement and apoB/apoAI ratio ... Ala., March 17 /PRNewswire/ -- ... VAP(R) Cholesterol Test in booth #1263 at ACC.09, the ... Exposition. The annual meeting takes place March 29-31, 2009, ...
Cached Biology Technology:Slimmer, stickier nanorods give boost to 3-D computer chips 2Heart Disease: An Epidemic For Firefighters 2Heart Disease: An Epidemic For Firefighters 3Atherotech to Exhibit the VAP(R) Cholesterol Test at ACC.09 in Orlando 2Atherotech to Exhibit the VAP(R) Cholesterol Test at ACC.09 in Orlando 3
(Date:7/24/2014)... new study has identified two factors that characterize ... the production of highly qualified physics teachers. Specifically, ... champion physics teacher education in combination with institutional ... remain viable. Science, Technology, Engineering and Math (STEM) ... the study points the way for institutions seeking ...
(Date:7/24/2014)... biodiversity, the product of 3.5 billion years of evolutionary ... of life. But it may be reaching a tipping ... and analysis of data published in Science , ... and decline of animals is contributing to what appears ... mass biological extinction event. , Since 1500, more than ...
(Date:7/24/2014)... its own microbial terroir, meaning the microbial populations found ... the product, creating the final flavor according to research ... and Environmental Microbiology . This is the first time ... brewery. , Many sake makers inoculate with both ... of the University of California, Davis, but he and ...
Breaking Biology News(10 mins):Creating sustainable STEM teacher preparation programs 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 3The microbes make the sake brewery 2
... Michigan have shown that their new metabolic imaging instrument can ... a device would be vision-saving because many severe eye diseases ... diminish vision. The testing is noninvasive and takes less than ... recent study, two researchers from the U-M Kellogg Eye Center ...
... memory works is emerging from a newfound ability to ... changes in the inner workings of its neurons. Researchers, ... National Institute of Mental Health (NIMH), have developed a ... a specific memory in genetically-engineered mice. "Remarkably, this ...
... threatening the staple diet of millions in Africa ... today, bringing together plant experts from Leeds and ... Urwin from the University of Leeds Faculty of ... 7 million Sustainable Agriculture Research for International Development ...
Cached Biology News:'Fluorescent' cells give early warning for eye disease 2Genetic tags reveal secrets of memories' staying power in mice 2Genetic tags reveal secrets of memories' staying power in mice 3Purging the plantain pests in Africa 2
Ms anti-Cyclophilin D...
... Intended to qualitatively detect ... formalin-fixed, paraffin-embedded (FFPE) tissue ... and cell preparations, using ... (CISH). Fluorescent In Situ ...
Mouse GM CSF Construction Kit provides antigen affinity purified polyclonal capture and tracer antibodies, and antigen standard for development of approximately ten microplate assays....
Many mammalian cell types and experimental situations create challenges for standard transfection experiments. The ViraPower Lentiviral Expression System overcomes these challenges with efficient...
Biology Products: